Non-operative Management in Locally Advanced Rectal Cancer Patients with Clinical Complete Response After Chemoradiotherapy Followed by Consolidation Chemotherapy: A Single Center Experience

Purpose This study aims to analyze the long-term clinical outcomes of non-operative management (NOM) in locally advanced mid/distal rectal cancer patients who had a complete clinical response (cCR) following neoadjuvant chemoradiotherapy (nCRT) and consolidation chemotherapy. Methods Locally advanced mid/distal rectal cancer patients with stage II/III amenable for surgery who received nCRT followed by consolidation chemotherapy were enrolled into this study. Patients with an incomplete response following nCRT at any stage underwent surgery and patients with a significant clinical response were treated with FOLFOX (5-fluorouracil and oxaliplatin) or CapeOx (capecitabine and oxaliplatin). Patients with a cCR after nCRT followed by consolidation chemotherapy were managed with NOM. Results A total of 173 patients treated between January 2014 and March 2025 were enrolled in this observational cohort study. All of these patients were treated with total neoadjuvant treatment and received especially nCRT and consolidation chemotherapy. 83 patients with cCR were followed up with NOM. The rate of local regrowth was 19.3% (n = 16) with all patients having an endoluminal growing pattern confined to the first two years. Distant metastases were diagnosed in 7 (8.4%) out of 83 patients. Disease-free survival and overall survival were 78.3% and 95.2%. Conclusion The long-term clinical outcomes of NOM were promising in terms of pelvic tumor control and overall survival in strictly selected patients who had cCR after nCRT followed by consolidation chemotherapy.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-19
DOI
https://doi.org/10.21203/rs.3.rs-11586656/v1
Primary Topic
Colorectal Cancer Surgical Treatments
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Non-operative Management in Locally Advanced Rectal Cancer Patients with Clinical Complete Response After Chemoradiotherapy Followed by Consolidation Chemotherapy: A Single Center Experience

Cemil Burak Kulle, Neslihan Kayisoglu Berker, İlker Özgür, Metin Keskin et al.
Research Square
Colorectal Cancer Surgical Treatments
preprint

Non-operative Management in Locally Advanced Rectal Cancer Patients with Clinical Complete Response After Chemoradiotherapy Followed by Consolidation Chemotherapy: A Single Center Experience

Cemil Burak Kulle, Neslihan Kayisoglu Berker, İlker Özgür, Metin Keskin, Nihan Nizam, Adem Bayraktar, Senem Karabulut, İrem Gider, Mehmet Türker Bulut, Merve Gülbiz Dağoğlu Kartal, Rabia Nergiz Dağoğlu Sakin, Melek Narin
preprint en

Abstract

Purpose This study aims to analyze the long-term clinical outcomes of non-operative management (NOM) in locally advanced mid/distal rectal cancer patients who had a complete clinical response (cCR) following neoadjuvant chemoradiotherapy (nCRT) and consolidation chemotherapy. Methods Locally advanced mid/distal rectal cancer patients with stage II/III amenable for surgery who received nCRT followed by consolidation chemotherapy were enrolled into this study. Patients with an incomplete response following nCRT at any stage underwent surgery and patients with a significant clinical response were treated with FOLFOX (5-fluorouracil and oxaliplatin) or CapeOx (capecitabine and oxaliplatin). Patients with a cCR after nCRT followed by consolidation chemotherapy were managed with NOM. Results A total of 173 patients treated between January 2014 and March 2025 were enrolled in this observational cohort study. All of these patients were treated with total neoadjuvant treatment and received especially nCRT and consolidation chemotherapy. 83 patients with cCR were followed up with NOM. The rate of local regrowth was 19.3% (n = 16) with all patients having an endoluminal growing pattern confined to the first two years. Distant metastases were diagnosed in 7 (8.4%) out of 83 patients. Disease-free survival and overall survival were 78.3% and 95.2%. Conclusion The long-term clinical outcomes of NOM were promising in terms of pelvic tumor control and overall survival in strictly selected patients who had cCR after nCRT followed by consolidation chemotherapy.

Research Square
Istanbul University (TR)
Colorectal Cancer Surgical Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon